Lattimore Keri A, Donn Steven M, Kaciroti Niko, Kemper Alex R, Neal Charles R, Vazquez Delia M
Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Michigan, Ann Arbor, MI 48109-0254, USA.
J Perinatol. 2005 Sep;25(9):595-604. doi: 10.1038/sj.jp.7211352.
Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy and the postpartum period. These drugs are capable of crossing the placenta and being transferred to the newborn during lactation. This report reviews the available information regarding the effects of SSRIs on the fetus and newborn; including long-term neurodevelopmental outcomes.
选择性5-羟色胺再摄取抑制剂（SSRI）常用于治疗孕期及产后抑郁。这些药物能够穿过胎盘，并在哺乳期转移至新生儿体内。本报告回顾了关于SSRI对胎儿及新生儿影响的现有信息，包括长期神经发育结局。
